309 related articles for article (PubMed ID: 21587066)
1. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity.
Oh DY; Lagakos WS
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):322-7. PubMed ID: 21587066
[TBL] [Abstract][Full Text] [Related]
2. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
Im DS
Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
[TBL] [Abstract][Full Text] [Related]
3. Anti-Inflammatory and Insulin-Sensitizing Effects of Free Fatty Acid Receptors.
Miyamoto J; Kasubuchi M; Nakajima A; Kimura I
Handb Exp Pharmacol; 2017; 236():221-231. PubMed ID: 27873088
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding receptors and their physiological role in type 2 diabetes.
Swaminath G
Arch Pharm (Weinheim); 2008 Dec; 341(12):753-61. PubMed ID: 19009545
[TBL] [Abstract][Full Text] [Related]
5. Combined Deletion of Free Fatty-Acid Receptors 1 and 4 Minimally Impacts Glucose Homeostasis in Mice.
Croze ML; Guillaume A; Ethier M; Fergusson G; Tremblay C; Campbell SA; Maachi H; Ghislain J; Poitout V
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33543237
[TBL] [Abstract][Full Text] [Related]
6. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.
Talukdar S; Olefsky JM; Osborn O
Trends Pharmacol Sci; 2011 Sep; 32(9):543-50. PubMed ID: 21663979
[TBL] [Abstract][Full Text] [Related]
7. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
Zhang X; Macielag MJ
Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
[TBL] [Abstract][Full Text] [Related]
8. Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics.
Yonezawa T; Kurata R; Yoshida K; Murayama MA; Cui X; Hasegawa A
Curr Med Chem; 2013; 20(31):3855-71. PubMed ID: 23862620
[TBL] [Abstract][Full Text] [Related]
9. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids.
Muredda L; Kępczyńska MA; Zaibi MS; Alomar SY; Trayhurn P
Arch Physiol Biochem; 2018 May; 124(2):97-108. PubMed ID: 28835131
[TBL] [Abstract][Full Text] [Related]
10. FFAR4 (GPR120) Signaling Is Not Required for Anti-Inflammatory and Insulin-Sensitizing Effects of Omega-3 Fatty Acids.
Pærregaard SI; Agerholm M; Serup AK; Ma T; Kiens B; Madsen L; Kristiansen K; Jensen BA
Mediators Inflamm; 2016; 2016():1536047. PubMed ID: 27999451
[TBL] [Abstract][Full Text] [Related]
11. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
[TBL] [Abstract][Full Text] [Related]
12. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
Im DS
Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
[TBL] [Abstract][Full Text] [Related]
13. Free fatty acid receptors and drug discovery.
Hirasawa A; Hara T; Katsuma S; Adachi T; Tsujimoto G
Biol Pharm Bull; 2008 Oct; 31(10):1847-51. PubMed ID: 18827341
[TBL] [Abstract][Full Text] [Related]
14. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.
Oh DY; Talukdar S; Bae EJ; Imamura T; Morinaga H; Fan W; Li P; Lu WJ; Watkins SM; Olefsky JM
Cell; 2010 Sep; 142(5):687-98. PubMed ID: 20813258
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.
Ichimura A; Hirasawa A; Poulain-Godefroy O; Bonnefond A; Hara T; Yengo L; Kimura I; Leloire A; Liu N; Iida K; Choquet H; Besnard P; Lecoeur C; Vivequin S; Ayukawa K; Takeuchi M; Ozawa K; Tauber M; Maffeis C; Morandi A; Buzzetti R; Elliott P; Pouta A; Jarvelin MR; Körner A; Kiess W; Pigeyre M; Caiazzo R; Van Hul W; Van Gaal L; Horber F; Balkau B; Lévy-Marchal C; Rouskas K; Kouvatsi A; Hebebrand J; Hinney A; Scherag A; Pattou F; Meyre D; Koshimizu TA; Wolowczuk I; Tsujimoto G; Froguel P
Nature; 2012 Feb; 483(7389):350-4. PubMed ID: 22343897
[TBL] [Abstract][Full Text] [Related]
16. GPR120: Mechanism of action, role and potential for medical applications.
Karakuła-Juchnowicz H; Róg J; Juchnowicz D; Morylowska-Topolska J
Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):942-953. PubMed ID: 29176006
[TBL] [Abstract][Full Text] [Related]
17. [Free fatty acid receptors and their physiological role in metabolic regulation].
Hirasawa A; Hara T; Ichimura A; Tsujimoto G
Yakugaku Zasshi; 2011; 131(12):1683-9. PubMed ID: 22129861
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid receptors as new therapeutic targets for diabetes.
Rayasam GV; Tulasi VK; Davis JA; Bansal VS
Expert Opin Ther Targets; 2007 May; 11(5):661-71. PubMed ID: 17465724
[TBL] [Abstract][Full Text] [Related]
20. Nutritional Signaling via Free Fatty Acid Receptors.
Miyamoto J; Hasegawa S; Kasubuchi M; Ichimura A; Nakajima A; Kimura I
Int J Mol Sci; 2016 Mar; 17(4):450. PubMed ID: 27023530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
